357 related articles for article (PubMed ID: 29417799)
1. A synthesis of the world's guidelines on photodynamic therapy for non-melanoma skin cancer.
Morton CA
G Ital Dermatol Venereol; 2018 Dec; 153(6):783-792. PubMed ID: 29417799
[TBL] [Abstract][Full Text] [Related]
2. European guidelines for topical photodynamic therapy part 1: treatment delivery and current indications - actinic keratoses, Bowen's disease, basal cell carcinoma.
Morton CA; Szeimies RM; Sidoroff A; Braathen LR
J Eur Acad Dermatol Venereol; 2013 May; 27(5):536-44. PubMed ID: 23181594
[TBL] [Abstract][Full Text] [Related]
3. European Dermatology Forum guidelines on topical photodynamic therapy 2019 Part 1: treatment delivery and established indications - actinic keratoses, Bowen's disease and basal cell carcinomas.
Morton CA; Szeimies RM; Basset-Seguin N; Calzavara-Pinton P; Gilaberte Y; Haedersdal M; Hofbauer GFL; Hunger RE; Karrer S; Piaserico S; Ulrich C; Wennberg AM; Braathen LR
J Eur Acad Dermatol Venereol; 2019 Dec; 33(12):2225-2238. PubMed ID: 31779042
[TBL] [Abstract][Full Text] [Related]
4. Daylight Photodynamic Therapy for Actinic Keratoses.
Morton CA; Braathen LR
Am J Clin Dermatol; 2018 Oct; 19(5):647-656. PubMed ID: 29752702
[TBL] [Abstract][Full Text] [Related]
5. The France-PDT study: a national prospective observational cohort survey on the use of methyl-aminolevulinate photodynamic therapy in France, with up to 6-month follow-up.
Farhi D; Bedane C; Savary J; Basset-Seguin N
Eur J Dermatol; 2013; 23(1):68-76. PubMed ID: 23400280
[TBL] [Abstract][Full Text] [Related]
6. Daylight photodynamic therapy with methyl aminolaevulinate in patients with actinic keratoses: a preliminary experience in Southern Italy.
Fai D; Romano I; Fai C; Cassano N; Vena GA
G Ital Dermatol Venereol; 2016 Apr; 151(2):154-9. PubMed ID: 25279493
[TBL] [Abstract][Full Text] [Related]
7. Methyl-aminolevulinate photodynamic therapy for the treatment of actinic keratoses and non-melanoma skin cancers: a retrospective analysis of response in 462 patients.
Fai D; Arpaia N; Romano I; Vestita M; Cassano N; Vena GA
G Ital Dermatol Venereol; 2009 Jun; 144(3):281-5. PubMed ID: 19528909
[TBL] [Abstract][Full Text] [Related]
8. Photodynamic therapy with violet light and topical 6-aminolaevulinic acid in the treatment of actinic keratosis, Bowen's disease and basal cell carcinoma.
Dijkstra AT; Majoie IM; van Dongen JW; van Weelden H; van Vloten WA
J Eur Acad Dermatol Venereol; 2001 Nov; 15(6):550-4. PubMed ID: 11843215
[TBL] [Abstract][Full Text] [Related]
9. Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group.
Morton CA; Brown SB; Collins S; Ibbotson S; Jenkinson H; Kurwa H; Langmack K; McKenna K; Moseley H; Pearse AD; Stringer M; Taylor DK; Wong G; Rhodes LE
Br J Dermatol; 2002 Apr; 146(4):552-67. PubMed ID: 11966684
[TBL] [Abstract][Full Text] [Related]
10. European guidelines for topical PDT part 1 JEADV 2013; 27: 536-544.
Skaria AM
J Eur Acad Dermatol Venereol; 2014 May; 28(5):673. PubMed ID: 23981061
[No Abstract] [Full Text] [Related]
11. Fractionated aminolevulinic acid-photodynamic therapy provides additional evidence for the use of PDT for non-melanoma skin cancer.
de Haas ER; de Vijlder HC; Sterenborg HJ; Neumann HA; Robinson DJ
J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):426-30. PubMed ID: 18031503
[TBL] [Abstract][Full Text] [Related]
12. Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005.
Braathen LR; Szeimies RM; Basset-Seguin N; Bissonnette R; Foley P; Pariser D; Roelandts R; Wennberg AM; Morton CA;
J Am Acad Dermatol; 2007 Jan; 56(1):125-43. PubMed ID: 17190630
[TBL] [Abstract][Full Text] [Related]
13. Response to Letter to the editor: 'European guidelines for topical PDT part 1. JEADV 2013;27:536-544' DOI: 10.1111/jdv.12258.
Morton CA; Szeimies RM; Sidoroff A; Braathen LR
J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1451-2. PubMed ID: 24666245
[No Abstract] [Full Text] [Related]
14. Methyl aminolevulinate-PDT for actinic keratoses and superficial nonmelanoma skin cancers.
Ortiz-Policarpio B; Lui H
Skin Therapy Lett; 2009; 14(6):1-3. PubMed ID: 19609473
[TBL] [Abstract][Full Text] [Related]
15. Huge Bowen's disease: a pitfall of topical photodynamic therapy.
Park JY; Kim SK; Cho KH; Kim YC
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):546-8. PubMed ID: 24284109
[TBL] [Abstract][Full Text] [Related]
16. Fractionated illumination improves the outcome in the treatment of precancerous lesions with photodynamic therapy.
Puizina-Ivić N; Zorc H; Vanjaka-Rogosić L; Mirić L; Persin A
Coll Antropol; 2008 Oct; 32 Suppl 2():67-73. PubMed ID: 19138010
[TBL] [Abstract][Full Text] [Related]
17. Topical 5-aminolaevulinic acid photodynamic therapy for cutaneous lesions: outcome and comparison of light sources.
Clark C; Bryden A; Dawe R; Moseley H; Ferguson J; Ibbotson SH
Photodermatol Photoimmunol Photomed; 2003 Jun; 19(3):134-41. PubMed ID: 12914598
[TBL] [Abstract][Full Text] [Related]
18. Photodynamic therapy for nonmelanoma skin cancers. Current review and update.
Zeitouni NC; Oseroff AR; Shieh S
Mol Immunol; 2003 Jul; 39(17-18):1133-6. PubMed ID: 12835091
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of the clinical, histological, and biological characteristics of squamous cell carcinomas in areas previously treated with photodynamic therapy.
Gracia Cazaña T; Salazar N; Vera-Álvarez J; González S; Juarranz A; Gilaberte Y
Eur J Dermatol; 2017 Dec; 27(6):627-634. PubMed ID: 29141833
[TBL] [Abstract][Full Text] [Related]
20. Photodynamic therapy for non-melanoma skin cancer.
Fien SM; Oseroff AR
J Natl Compr Canc Netw; 2007 May; 5(5):531-40. PubMed ID: 17509255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
